Narnatumab

From WikiProjectMed
Jump to navigation Jump to search
Narnatumab
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetMST1R (aka RON)
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6454H10026N1754O2020S44
Molar mass145922.10 g·mol−1
 ☒NcheckY (what is this?)  (verify)

Narnatumab is a human monoclonal antibody designed for the treatment of cancer.[1] Clinical development was abandoned after phase I trials.[2]

Narnatumab was developed by ImClone Systems.

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Narnatumab" (PDF). American Medical Association.
  2. ^ "Narnatumumab". AdisInsight. Retrieved 31 January 2017.